Skip to main content

Table 1 Correct knowledge related to viral hepatitis transmission among individuals aged between 15 and 64 years according to sex and age in Brazil as measured by the PCAP-2013

From: State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013)

  Men Women
  Total 15–24 years 25–49 years 50–64 years All age groups p-value 15–24 years 25–49 years 50–64 years All age groups p-value
Unprotected sexual intercourse
 HBV 33.1 (30.3–35.9) 41.6 (33.8–49.9) 37.3 (32.5–42.4) 32.7 (26.0–40.2) 37.5 (33.0–42.3) 0.17 27.9 (22.1–34.5) 30.1 (26.0–34.7) 23.9 (18.6–30.1) 28.6 (25.4–32.0) 0.27
 HCV 34.3 (31.6–37.0) 33.1 (26.4–40.6) 36.8 (32.2–41.8) 30.6 (24.1–37.9) 34.9 (31.1–38.9) 0.29 27.5 (21.5–34.4) 38.2 (33.5–43.2) 25.6 (19.9–32.1) 33.7 (30.3–37.3) 0.002
 HBV/HCV 17.1 (14.8–19.5) 17.2 (12.1–23.7) 19.3 (15.6–23.7) 18 (13.0–24.3) 18.6 (15.3–22.4) 0.72 12.8 (8.7–18.4) 17.7 (14.3–21.8) 11.6 (7.9–16.6) 15.6 (13.0–18.6) 0.06
Sharing needles
 HBV 30.0 (27.5–32.6) 25.8 (20.4–32.1) 32 (27.7–36.8) 29.7 (23.5–36.7) 30.1 (65.8–34.2) 0.13 29.4 (23.9–35.6) 29.9 (26.2–33.9) 30.8 (24.7–37.7) 29.9 (26.8–33.2) 0.95
 HCV 27.0 (24.7–29.3) 25.8 (20.3–32.2) 28.5 (24.4–32.9) 25.2 (19.7–31.7) 27.3 (23.9–30.8) 0.57 21.5 (16.8–27.2) 30.1 (26.5–34.0) 21.0 (16.3–26.6) 26.6 (23.9–29.5) 0.004
 HBV/HCV 12.0 (10.3–13.8) 10.4 (6.8–15.4) 13.5 (10.9–16.7) 12.6 (8.4–18.6) 12.6 (10.3–15.4) 0.43 10.3 (6.9–15.2) 12.3 (9.9–15.1) 9.6 (6.6–13.9) 11.4 (9.5–13.7) 0.45
Sharing manicure/pedicure equipment
 HBV 30.4 (28.2–32.6) 30 (23.8–37.0) 30 (25.8–34.5) 31.4 (25.6–37.9) 30.2 (26.6–34.1) 0.90 31.5 (27.1–36.2) 31.7 (28.5–35.0) 25.2 (20.9–30.0) 30.6 (28.0–33.3) 0.06
 HCV 27.2 (25.0–29.4) 31.1 (24.9–38.0) 28.8 (25.1–32.8) 23.4 (18.5–29.0) 28.4 (25.2–31.8) 0.15 24.2 (20.0–28.9) 28.0 (24.8–31.4) 23.2 (19.2–27.8) 26.3 (23.8–29.0) 0.12
 HBV/HCV 9.7 (8.2–11.2) 11.3 (7.1–17.6) 10.5 (8.1–13.6) 11.8 (8.4–16.3) 10.9 (8.7–13.6) 0.85 7.7 (5.5–10.9) 9.4 (7.4–11.7) 8.2 (5.9–11.2) 8.8 (7.3–10.6) 0.52
Dental treatment, dialysis or endoscopy
 HBV 28.0 (25.6–30.4) 24.7 (19.0–31.5) 25.4 (21.7–29.5) 28.9 (22.7–35.9) 25.9 (22.6–29.5) 0.56 29.0 (23.3–35.4) 30.1 (26.4–34.2) 30.2 (24.4–36.6) 29.9 (26.7–33.3) 0.93
 HCV 27.4 (25.1–30.0) 27 (21.0–33.9) 30.3 (26.2–34.8) 22.7 (17.6–28.8) 28.2 (24.8–31.2) 0.10 24.6 (19.5–30.6) 27.9 (24.1–32.1) 24.5 (19.5–30.3) 26.6 (23.6–29.9) 0.42
 HBV/HCV 10.6 (9.0–12.2) 8.6 (5.3–13.6) 9.1 (7.0–11.9) 11.6 (7.8–16.9) 9.5 (7.6–11.8) 0.53 9.5 (6.4–13.9) 12.5 (9.9–15.7) 10.9 (7.6–15.5) 11.6 (9.5–14.1) 0.37
Tattooing or piercing
 HBV 26.4 (24.0–28.7) 22.5 (17.3–28.8) 26.4 (22.5–30.8) 27.0 (21.0–34.1) 25.6 (22.3–29.2) 0.43 23.5 (18.6–29.2) 29.3 (25.6–33.4) 23.6 (18.7–29.5) 27.1 (24.1–30.3) 0.07
 HCV 24.5 (27.1–31.8) 30.3 (23.8–37.7) 28.9 (24.8–33.3) 28.3 (22.1–35.5) 29.1 (25.7–32.9) 0.89 23.6 (18.6–29.4) 33.4 (29.6–37.4) 25.1 (20.0–31.1) 29.8 (26.932.8) 0.003
 HBV/HCV 11.3 (9.6–13.0) 7.9 (4.9–12.5) 10.3 (7.8–13.5) 11.8 (7.9–17.0) 10.0 (7.9–12.5) 0.37 9.0 (6.0–13.4) 15.1 (12.3–18.4) 7.9 (5.3–11.6) 12.5 (10.4–15.0) 0.001
Denominators
 Unweighted 12000 1503 3002 1495 6000   1499 3002 1499 6000  
 Weighted 12000 1577 3208 1081 5867   1565 3362 1207 6133  
  1. Percentages indicate those with correct knowledge related to viral hepatitis transmission. The data in parentheses are 95 % CIs